Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 118.37
   
  • Change Today:
    $-0.65
  • 52 Week High: $120.47
  • 52 Week Low: $72.73
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 8,859,872
  • Market Cap: $147,489m
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 118.37
Change Today $ -0.65
% Change -0.55 %
52 Week High $120.47
52 Week Low $72.73
Volume 8,859,872
Shares Issued 1,246.00m
Market Cap $147,489m
RiskGrade 120

What The Brokers Say

Strong Buy 10
Buy 11
Neutral 6
Sell 1
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 15-Aug-2025

Time Volume / Share Price
16:00 1,278,419 @ $118.37
15:59 111 @ $118.31
15:59 300 @ $118.33
15:59 6,900 @ $118.32
15:59 200 @ $118.32

Top of Page